The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy

D. L. Fung, D. A. White, G. A. Gronert, E. Disbrow

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Immobilization of skeletal muscle results in disuse atrophy and resistance to nondepolarizing muscle relaxants. We studied the pharmacodynamics of metocurine (MTC) to identify the development and recovery of disuse-related resistance to MTC. Methods: Nineteen dogs underwent cast immobilization of a hind limb for as long as 3 weeks. Before, during, and after casting, dogs were intermittently anesthetized with thiamylal-N2O- fentanyl. The blood concentration of MTC and the corresponding degree of paralysis after a brief infusion were recorded and were used to characterize the pharmacokinetics and pharmacodynamics of MTC. Result: Pharmacodynamic study of the response to MTC demonstrated resistance by the 4th day of casting. The effect-site concentration associated with 50% paralysis of twitch increased after 3 weeks from approximately 250 to 750 ng/ml. After cast removal, resistance persisted for 2 more weeks. Six weeks after cast removal, the effect-site concentration associated with 50% paralysis of twitch was normal in every dog. Conclusions: Within the context of this study of immobilization disuse atrophy, pharmacokinetic and pharmacodynamic characterization of antagonist responses can be used to infer muscle disuse- related changes in acetylcholine receptors.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalAnesthesiology
Volume83
Issue number1
DOIs
StatePublished - 1995

Fingerprint

Atrophic Muscular Disorders
Canidae
Paralysis
Immobilization
Dogs
Pharmacokinetics
Thiamylal
Muscles
Fentanyl
Cholinergic Receptors
Skeletal Muscle
Extremities
metocurine

Keywords

  • Muscle, skeletal: disuse atrophy; immobilization
  • Neuromuscular relaxants, nondepolarizing: metocurine
  • Pharmacodynamics: metocurine
  • Pharmacokinetics: metocurine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy. / Fung, D. L.; White, D. A.; Gronert, G. A.; Disbrow, E.

In: Anesthesiology, Vol. 83, No. 1, 1995, p. 134-140.

Research output: Contribution to journalArticle

Fung, D. L. ; White, D. A. ; Gronert, G. A. ; Disbrow, E. / The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy. In: Anesthesiology. 1995 ; Vol. 83, No. 1. pp. 134-140.
@article{41b1cea304b145f48d2a21a00705e36a,
title = "The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy",
abstract = "Background: Immobilization of skeletal muscle results in disuse atrophy and resistance to nondepolarizing muscle relaxants. We studied the pharmacodynamics of metocurine (MTC) to identify the development and recovery of disuse-related resistance to MTC. Methods: Nineteen dogs underwent cast immobilization of a hind limb for as long as 3 weeks. Before, during, and after casting, dogs were intermittently anesthetized with thiamylal-N2O- fentanyl. The blood concentration of MTC and the corresponding degree of paralysis after a brief infusion were recorded and were used to characterize the pharmacokinetics and pharmacodynamics of MTC. Result: Pharmacodynamic study of the response to MTC demonstrated resistance by the 4th day of casting. The effect-site concentration associated with 50{\%} paralysis of twitch increased after 3 weeks from approximately 250 to 750 ng/ml. After cast removal, resistance persisted for 2 more weeks. Six weeks after cast removal, the effect-site concentration associated with 50{\%} paralysis of twitch was normal in every dog. Conclusions: Within the context of this study of immobilization disuse atrophy, pharmacokinetic and pharmacodynamic characterization of antagonist responses can be used to infer muscle disuse- related changes in acetylcholine receptors.",
keywords = "Muscle, skeletal: disuse atrophy; immobilization, Neuromuscular relaxants, nondepolarizing: metocurine, Pharmacodynamics: metocurine, Pharmacokinetics: metocurine",
author = "Fung, {D. L.} and White, {D. A.} and Gronert, {G. A.} and E. Disbrow",
year = "1995",
doi = "10.1097/00000542-199507000-00017",
language = "English (US)",
volume = "83",
pages = "134--140",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The changing pharmacodynamics of metocurine identify the onset and offset of canine gastrocnemius disuse atrophy

AU - Fung, D. L.

AU - White, D. A.

AU - Gronert, G. A.

AU - Disbrow, E.

PY - 1995

Y1 - 1995

N2 - Background: Immobilization of skeletal muscle results in disuse atrophy and resistance to nondepolarizing muscle relaxants. We studied the pharmacodynamics of metocurine (MTC) to identify the development and recovery of disuse-related resistance to MTC. Methods: Nineteen dogs underwent cast immobilization of a hind limb for as long as 3 weeks. Before, during, and after casting, dogs were intermittently anesthetized with thiamylal-N2O- fentanyl. The blood concentration of MTC and the corresponding degree of paralysis after a brief infusion were recorded and were used to characterize the pharmacokinetics and pharmacodynamics of MTC. Result: Pharmacodynamic study of the response to MTC demonstrated resistance by the 4th day of casting. The effect-site concentration associated with 50% paralysis of twitch increased after 3 weeks from approximately 250 to 750 ng/ml. After cast removal, resistance persisted for 2 more weeks. Six weeks after cast removal, the effect-site concentration associated with 50% paralysis of twitch was normal in every dog. Conclusions: Within the context of this study of immobilization disuse atrophy, pharmacokinetic and pharmacodynamic characterization of antagonist responses can be used to infer muscle disuse- related changes in acetylcholine receptors.

AB - Background: Immobilization of skeletal muscle results in disuse atrophy and resistance to nondepolarizing muscle relaxants. We studied the pharmacodynamics of metocurine (MTC) to identify the development and recovery of disuse-related resistance to MTC. Methods: Nineteen dogs underwent cast immobilization of a hind limb for as long as 3 weeks. Before, during, and after casting, dogs were intermittently anesthetized with thiamylal-N2O- fentanyl. The blood concentration of MTC and the corresponding degree of paralysis after a brief infusion were recorded and were used to characterize the pharmacokinetics and pharmacodynamics of MTC. Result: Pharmacodynamic study of the response to MTC demonstrated resistance by the 4th day of casting. The effect-site concentration associated with 50% paralysis of twitch increased after 3 weeks from approximately 250 to 750 ng/ml. After cast removal, resistance persisted for 2 more weeks. Six weeks after cast removal, the effect-site concentration associated with 50% paralysis of twitch was normal in every dog. Conclusions: Within the context of this study of immobilization disuse atrophy, pharmacokinetic and pharmacodynamic characterization of antagonist responses can be used to infer muscle disuse- related changes in acetylcholine receptors.

KW - Muscle, skeletal: disuse atrophy; immobilization

KW - Neuromuscular relaxants, nondepolarizing: metocurine

KW - Pharmacodynamics: metocurine

KW - Pharmacokinetics: metocurine

UR - http://www.scopus.com/inward/record.url?scp=0029004227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029004227&partnerID=8YFLogxK

U2 - 10.1097/00000542-199507000-00017

DO - 10.1097/00000542-199507000-00017

M3 - Article

C2 - 7604992

AN - SCOPUS:0029004227

VL - 83

SP - 134

EP - 140

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 1

ER -